Antiviral activity of animal venom peptides and related compounds
AUTOR(ES)
Mata, Élida Cleyse Gomes da, Mourão, Caroline Barbosa Farias, Rangel, Marisa, Schwartz, Elisabeth Ferroni
FONTE
J. Venom. Anim. Toxins incl. Trop. Dis
DATA DE PUBLICAÇÃO
20/02/2017
RESUMO
Abstract Viruses exhibit rapid mutational capacity to trick and infect host cells, sometimes assisted through virus-coded peptides that counteract host cellular immune defense. Although a large number of compounds have been identified as inhibiting various viral infections and disease progression, it is urgent to achieve the discovery of more effective agents. Furthermore, proportionally to the great variety of diseases caused by viruses, very few viral vaccines are available, and not all are efficient. Thus, new antiviral substances obtained from natural products have been prospected, including those derived from venomous animals. Venoms are complex mixtures of hundreds of molecules, mostly peptides, that present a large array of biological activities and evolved to putatively target the biochemical machinery of different pathogens or host cellular structures. In addition, non-venomous compounds, such as some body fluids of invertebrate organisms, exhibit antiviral activity. This review provides a panorama of peptides described from animal venoms that present antiviral activity, thereby reinforcing them as important tools for the development of new therapeutic drugs.
Documentos Relacionados
- Antiviral and Antitumor Antibiotics. XX. Effects of Rotenone, Deguelin, and Related Compounds on Animal and Plant Viruses
- Structure-activity relationships of new antiviral compounds.
- Antiviral activity of influenza virus M1 zinc finger peptides.
- Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.
- Antiviral activity of antilipidemic compounds on herpes simplex virus type 1.